6LPL image
Entry Detail
PDB ID:
6LPL
Title:
A2AR crystallized in EROCOC17+4, SS-ROX at 100 K
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-01-11
Release Date:
2020-11-25
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a
Chain IDs:A
Chain Length:447
Number of Molecules:1
Biological Source:Homo sapiens, Escherichia coli
Primary Citation
Isoprenoid-chained lipid EROCOC 17+4 : a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography.
Sci Rep 10 19305 19305 (2020)
PMID: 33168855 DOI: 10.1038/s41598-020-76277-x

Abstact

In meso crystallization of membrane proteins relies on the use of lipids capable of forming a lipidic cubic phase (LCP). However, almost all previous crystallization trials have used monoacylglycerols, with 1-(cis-9-octadecanoyl)-rac-glycerol (MO) being the most widely used lipid. We now report that EROCOC17+4 mixed with 10% (w/w) cholesterol (Fig. 1) serves as a new matrix for crystallization and a crystal delivery medium in the serial femtosecond crystallography of Adenosine A2A receptor (A2AR). The structures of EROCOC17+4-matrix grown A2AR crystals were determined at 2.0 Å resolution by serial synchrotron rotation crystallography at a cryogenic temperature, and at 1.8 Å by LCP-serial femtosecond crystallography, using an X-ray free-electron laser at 4 and 20 °C sample temperatures, and are comparable to the structure of the MO-matrix grown A2AR crystal (PDB ID: 4EIY). Moreover, X-ray scattering measurements indicated that the EROCOC17+4/water system did not form the crystalline LC phase at least down to - 20 °C, in marked contrast to the equilibrium MO/water system, which transforms into the crystalline LC phase below about 17 °C. As the LC phase formation within the LCP-matrix causes difficulties in protein crystallography experiments in meso, this feature of EROCOC17+4 will expand the utility of the in meso method.

Legend

Protein

Chemical

Disease

Primary Citation of related structures